Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Carcinoma, Anaplastic

1-methyl-3-isobutylxanthine has been researched along with Carcinoma, Anaplastic in 3 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nordeen, SK1
Moyer, ML1
Bona, BJ1
Daneker, GW1
Lund, SA1
Caughman, SW1
Staley, CA1
Wood, WC1
el-Tanani, MK1
Green, CD1

Other Studies

3 other studies available for 1-methyl-3-isobutylxanthine and Carcinoma, Anaplastic

ArticleYear
Modulation of glucocorticoid-regulated transcription by purines: novel characteristics and implications for tissue specificity of steroid responses.
    Endocrinology, 1995, Volume: 136, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Aminopyridines; Animals; Carcinoma; Gene Expression Regulation; Glucoco

1995
Anti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expression.
    Clinical & experimental metastasis, 1996, Volume: 14, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Antineoplastic Agents; Bucladesine; Carcinoma; Cell Adhesion; Cells, Cu

1996
Interaction between estradiol and cAMP in the regulation of specific gene expression.
    Molecular and cellular endocrinology, 1996, Nov-29, Volume: 124, Issue:1-2

    Topics: 1-Methyl-3-isobutylxanthine; Breast Neoplasms; Carcinoma; Cholera Toxin; Cyclic AMP; Cycloheximide;

1996